banner

Press Release

View printer-friendly version

<<  Back

ACADIA Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--May 5, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the following two investor conferences:

  • 2020 BofA Securities Health Care Conference on Tuesday, May 12, 2020, at 11:00 a.m. Eastern Time.
  • 2020 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2020, at 1:55 p.m. Eastern Time.

These conferences will both be held virtually. Live webcasts of ACADIA’s presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. ACADIA has developed and commercialized the first and only medicine approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. ACADIA also has ongoing clinical development efforts in additional areas with significant unmet need, including dementia-related psychosis, major depressive disorder, the negative symptoms of schizophrenia, and Rett syndrome. This press release and further information about ACADIA can be found at: www.acadia-pharm.com.

Media Contact:
ACADIA Pharmaceuticals Inc.
Stephanie Fagan
(858) 212-0534
media@acadia-pharm.com

Investor Contact:
ACADIA Pharmaceuticals Inc.
Mark Johnson, CFA
(858) 261-2771
ir@acadia-pharm.com

Source: ACADIA Pharmaceuticals Inc.